摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-ethyl-cyclohexanone oxime | 86823-11-2

中文名称
——
中文别名
——
英文名称
2-ethyl-cyclohexanone oxime
英文别名
2-Aethyl-cyclohexanon-oxim;2-Ethyl-1-(hydroxyimino)cyclohexane;N-(2-ethylcyclohexylidene)hydroxylamine
2-ethyl-cyclohexanone oxime化学式
CAS
86823-11-2
化学式
C8H15NO
mdl
——
分子量
141.213
InChiKey
HTRMWUORSYXIAP-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    91 °C
  • 沸点:
    120 °C(Press: 20 Torr)
  • 密度:
    1.05±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.1
  • 重原子数:
    10
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.88
  • 拓扑面积:
    32.6
  • 氢给体数:
    1
  • 氢受体数:
    2

反应信息

  • 作为反应物:
    描述:
    2-ethyl-cyclohexanone oximesodium 作用下, 以 乙醇 为溶剂, 以75%的产率得到cis-2-ethylcyclohexylamine
    参考文献:
    名称:
    Stereoselective reductions of substituted cyclohexyl and cyclopentyl carbon-nitrogen .pi. systems with hydride reagents
    摘要:
    DOI:
    10.1021/jo00168a009
  • 作为产物:
    描述:
    2-乙基环己酮盐酸羟胺sodium acetate 作用下, 以 乙醇 为溶剂, 以89%的产率得到2-ethyl-cyclohexanone oxime
    参考文献:
    名称:
    Stereoselective reductions of substituted cyclohexyl and cyclopentyl carbon-nitrogen .pi. systems with hydride reagents
    摘要:
    DOI:
    10.1021/jo00168a009
点击查看最新优质反应信息

文献信息

  • Novel guanidinobenzamides
    申请人:Chiron Corporation
    公开号:US20030199499A1
    公开(公告)日:2003-10-23
    Compounds of formula IIA and IIB are novel guanidine compounds 1 where the variables R 1 through R 10 have the values set forth herein. Such compounds have use in treating diseases such as obesity and type II diabetes, and may be provided as pharmaceutical formulations in conjunction with a pharmaceutically acceptable carrier.
    化学式为IIA和IIB的化合物是新型的胍类化合物,其中变量R1到R10的取值如下所述。这些化合物在治疗肥胖症和2型糖尿病等疾病方面具有用途,并可与药物可接受载体一起提供作为药物配方。
  • Guanidinobenzamides
    申请人:Chiron Corporation
    公开号:US06638927B2
    公开(公告)日:2003-10-28
    Compounds of formula IA and IB are new where the variables R1 through R10 have the values set forth herein. Such compounds have use in treating diseases such as obesity and type II diabetes, and may be provided as pharmaceutical formulations in conjunction with a pharmaceutically acceptable carrier.
    具有公式IA和IB的化合物是新的,其中变量R1到R10具有此处所列的值。这样的化合物在治疗肥胖症和2型糖尿病等疾病方面有用,并且可以与药用载体一起提供作为药物制剂。
  • 72. Synthetical and stereochemical investigations of reduced cyclic bases. Part I. Hydrogenation products of indole and the exhaustive methylation of an N-methyloctahydroindole
    作者:F. E. King、J. A. Barltrop、R. J. Walley
    DOI:10.1039/jr9450000277
    日期:——
  • 2-Iminohomopiperidinium Salts as Selective Inhibitors of Inducible Nitric Oxide Synthase (iNOS)
    作者:Donald W. Hansen,、Karen B. Peterson、Mahima Trivedi、Steven W. Kramer、Ronald K. Webber、Foe S. Tjoeng、William M. Moore、Gina M. Jerome、Christine M. Kornmeier、Pamela T. Manning、Jane R. Connor、Thomas P. Misko、Mark G. Currie、Barnett S. Pitzele
    DOI:10.1021/jm9704715
    日期:1998.4.1
    An attractive approach to the treatment of inflammatory conditions such as osteo-and rheumatoid arthritis, inflammatory bowel disease, and sepsis is through the selective inhibition of human inducible nitric oxide synthase (hiNOS) since localized excess nitric oxide (NO) release has been implicated in the pathology of these diseases. A series of monosubstituted iminohomopiperidinium salts possessing lipophilic functionality at ring positions 3, 5, 6, and 7 has been synthesized, and series members have demonstrated the ability to inhibit the hiNOS isoform with an IC50 as low as 160 nM (7). Compounds were found that selectively inhibit hiNOS over the human endothelial constitutive enzyme (heNOS) with a heNOS/hiNOS IC50 ratio in excess of 100 and as high as 314 (9). Potencies for inhibition of hiNOS and the human neuronal constitutive enzyme (hnNOS) are comparable. Substitution in the 3 and 7 positions provides compounds that exhibit the greatest degree of selectivity for hiNOS and hnNOS over heNOS. Submicromolar potencies for 6 and 7 in a mouse RAW cell assay demonstrated the ability of these compounds to inhibit iNOS in a cellular environment. These latter compounds were also found to be orally bioavailable and efficacious due to their ability to inhibit the increase in plasma nitrite/nitrate levels in a rat LPS model.
  • Stereoselective reductions of substituted cyclohexyl and cyclopentyl carbon-nitrogen .pi. systems with hydride reagents
    作者:Robert O. Hutchins、Wei Yang Su、Ramachandran Sivakumar、Frank Cistone、Yuriy P. Stercho
    DOI:10.1021/jo00168a009
    日期:1983.10
查看更多

同类化合物

(N-(2-甲基丙-2-烯-1-基)乙烷-1,2-二胺) (4-(苄氧基)-2-(哌啶-1-基)吡啶咪丁-5-基)硼酸 (11-巯基十一烷基)-,,-三甲基溴化铵 鼠立死 鹿花菌素 鲸蜡醇硫酸酯DEA盐 鲸蜡硬脂基二甲基氯化铵 鲸蜡基胺氢氟酸盐 鲸蜡基二甲胺盐酸盐 高苯丙氨醇 高箱鲀毒素 高氯酸5-(二甲氨基)-1-({(E)-[4-(二甲氨基)苯基]甲亚基}氨基)-2-甲基吡啶正离子 高氯酸2-氯-1-({(E)-[4-(二甲氨基)苯基]甲亚基}氨基)-6-甲基吡啶正离子 高氯酸2-(丙烯酰基氧基)-N,N,N-三甲基乙铵 马诺地尔 马来酸氢十八烷酯 马来酸噻吗洛尔EP杂质C 马来酸噻吗洛尔 马来酸倍他司汀 顺式环己烷-1,3-二胺盐酸盐 顺式氯化锆二乙腈 顺式吡咯烷-3,4-二醇盐酸盐 顺式双(3-甲氧基丙腈)二氯铂(II) 顺式3,4-二氟吡咯烷盐酸盐 顺式1-甲基环丙烷1,2-二腈 顺式-二氯-反式-二乙酸-氨-环己胺合铂 顺式-二抗坏血酸(外消旋-1,2-二氨基环己烷)铂(II)水合物 顺式-N,2-二甲基环己胺 顺式-4-甲氧基-环己胺盐酸盐 顺式-4-环己烯-1.2-二胺 顺式-4-氨基-2,2,2-三氟乙酸环己酯 顺式-2-甲基环己胺 顺式-2-(苯基氨基)环己醇 顺式-2-(氨基甲基)-1-苯基环丙烷羧酸盐酸盐 顺式-1,3-二氨基环戊烷 顺式-1,2-环戊烷二胺 顺式-1,2-环丁腈 顺式-1,2-双氨甲基环己烷 顺式--N,N'-二甲基-1,2-环己二胺 顺式-(R,S)-1,2-二氨基环己烷铂硫酸盐 顺式-(2-氨基-环戊基)-甲醇 顺-2-戊烯腈 顺-1,3-环己烷二胺 顺-1,3-双(氨甲基)环己烷 顺,顺-丙二腈 非那唑啉 靛酚钠盐 靛酚 霜霉威盐酸盐 霜脲氰